2026 Scientific Sessions

Lunch Program: 5 Years of Harmony TPV: Data Driven Evolution of Patient Care

Sponsored by Medtronic.

Join us as we explore how emerging data continues to shape the future of congenital structural heart interventions. As clinical evidence continues to mature, physicians are increasingly equipped to make more informed, data-driven decisions that optimize patient selection, procedural approaches, and long-term management—ultimately improving patient outcomes. This session will highlight the evolution of care for patients treated with the Harmony™ Transcatheter Pulmonary Valve (TPV), offering a comprehensive look at real-world experience since the therapy’s initial launch. Faculty will share key insights on patient selection criteria, procedural best practices, clinical outcomes, and complication management, as well as lessons learned that are informing next-generation innovation and care pathways. Attendees will gain a deeper understanding of how longitudinal data, physician experience, and iterative advancements are converging to refine treatment strategies and expand access to minimally invasive solutions for patients with complex congenital heart disease.

Lessons Learned from Clinical Experience: What Does the Data Tell Us
Bryan H. Goldstein, M.D., FSCAI, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
Coronary Interrogation Case Presentation
Joanna Ghobrial, M.D., FSCAI, The Cleveland Clinic Foundation, Cleveland, OH
Successful Implantation in Difficult Anatomies Case Presentation
Osamah Aldoss, M.D., FSCAI, Children's Wisconsin, Milwaukee, WI
Closing Thoughts
Bryan H. Goldstein, M.D., FSCAI, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA